Literature DB >> 2704749

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

J N Wilcox1, K M Smith, S M Schwartz, D Gordon.   

Abstract

Tissue factor (TF)-producing cells were identified in normal human vessels and atherosclerotic plaques by in situ hybridization and immunohistochemistry using a specific riboprobe for TF mRNA and a polyclonal antibody directed against human TF protein. TF mRNA and protein were absent from endothelial cells lining normal internal mammary artery and saphenous vein samples. In normal vessels TF was found to be synthesized in scattered cells present in the tunica media as well as fibroblast-like adventitial cells surrounding vessels. Atherosclerotic plaques contained many cells synthesizing TF mRNA and protein. Macrophages present as foam cells and monocytes adjacent to the cholesterol clefts contained TF mRNA and protein, as did mesenchymal-appearing intimal cells. Significant TF protein staining was found deposited in the extracellular matrix surrounding mRNA-positive cells adjacent to the cholesterol clefts and within the necrotic cores. These results suggest that deposition of TF protein in the matrix of the necrotic core of the atherosclerotic plaque may contribute to the hyperthrombotic state of human atherosclerotic vessels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2704749      PMCID: PMC287014          DOI: 10.1073/pnas.86.8.2839

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts.

Authors:  J R Maynard; B E Dreyer; M B Stemerman; F A Pitlick
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

2.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

Authors:  B Osterud; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 3.  The coronary thrombus: its origin and fate.

Authors:  M Friedman
Journal:  Hum Pathol       Date:  1971-03       Impact factor: 3.466

4.  Characterization of the coagulant activity of cultured human fibroblasts.

Authors:  D Green; C Ryan; N Malandruccolo; H L Nadler
Journal:  Blood       Date:  1971-01       Impact factor: 22.113

5.  Pathogenesis of cerebral artery thrombosis in man.

Authors:  P Constantinides
Journal:  Arch Pathol       Date:  1967-05

6.  The pathogenesis of a coronary thrombus.

Authors:  M Friedman; G J Van den Bovenkamp
Journal:  Am J Pathol       Date:  1966-01       Impact factor: 4.307

7.  Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi.

Authors:  M J Davies; N Woolf; W B Robertson
Journal:  Br Heart J       Date:  1976-07

8.  Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion.

Authors:  M P Bevilacqua; J S Pober; M E Wheeler; R S Cotran; M A Gimbrone
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

9.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

10.  Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section.

Authors:  T Horie; M Sekiguchi; K Hirosawa
Journal:  Br Heart J       Date:  1978-02
View more
  171 in total

Review 1.  New thrombolytics, anticoagulants, and platelet antagonists: the future of clinical practice.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

3.  Adjunctive Pharmacologic Treatment: Focus on the Development of Low Molecular Weight Heparins.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

4.  So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control.

Authors:  T S Edgington
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 5.  Antiinflammatory and immunomodulatory properties of statins.

Authors:  Ora Shovman; Yair Levy; Boris Gilburd; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 6.  Platelet activation in acute myocardial infarction and the rationale for combination therapy.

Authors:  I Conde-Pozzi; N Kleiman
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

7.  Invasion and killing of human endothelial cells by viridans group streptococci.

Authors:  Murray W Stinson; Susan Alder; Sarmishtha Kumar
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 8.  A guide to drug use during percutaneous coronary intervention.

Authors:  Joseph K Choo; John J Young; Dean J Kereiakes
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 9.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

10.  Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries.

Authors:  P Zoldhelyi; Z Q Chen; H S Shelat; J M McNatt; J T Willerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.